Speaker illustration

Miss Laura Marijke Willemsen

St Antonius Hospital, Nieuwegein (Netherlands (The))

Laura Willemsen studied Medicine at the University of Utrecht and graduated in 2015 after which she became as a PhD student at the Department of Cardiology in the St. Antonius Hospital Nieuwegein, supervised by Dr. J.M. ten Berg. Laura is coordinating investigator of the multicentre, randomized, double-blind, placebo-controlled POPular CABG trial, of which the results are presented at this ESC congress. In addition to that, Laura`s other research activities focus on cardiac surgery and thrombosis and haemostasis.

The effect of one year postoperative ticagrelor in addition to aspirin on saphenous vein graft patency in patients undergoing CABG – a randomized, multi-center, double-blind, placebo-controlled trial.

Event: ESC Congress 2020

Topic: Coronary Arteries

Session: Latest Randomized Results on Antiplatelet Therapy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb